RonaldJOudizMD

Clinical Trials

• Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication Start of enrollment: 2010 Aug 01

  Completed

  Phase 4

• Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01

  Completed

• Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26

  Completed

  Phase 3

• An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11

  Completed

  Phase 3

• Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01

  Completed

  Phase 3

• Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure Start of enrollment: 2013 Jul 01

  Withdrawn

  Phase 2

• Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31

  Completed

  Phase 3

• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Start of enrollment: 2014 May 31

  Completed

  Phase 2

• Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction Start of enrollment: 2014 Jul 01

  Completed

  Phase 2

• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18

  Terminated

  Phase 3

• Join now to see all